Avidity Biosciences, Inc. (RNA)
Largest Insider Buys in Sector
RNA Stock Price History Chart
RNA Stock Performance
About Avidity Biosciences, Inc.
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme …
Insider Activity of Avidity Biosciences, Inc.
Over the last 12 months, insiders at Avidity Biosciences, Inc. have bought $0 and sold $57.76M worth of Avidity Biosciences, Inc. stock.
On average, over the past 5 years, insiders at Avidity Biosciences, Inc. have bought $18.45M and sold $16.2M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 800,000 shares for transaction amount of $14.4M was made by RTW INVESTMENTS, LP (10 percent owner) on 2021‑08‑04.
List of Insider Buy and Sell Transactions, Avidity Biosciences, Inc.
| 2024-12-18 | Sale | President and CEO | 31,855 0.0283% | $32.66 | $1.04M | -2.62% | ||
| 2024-12-18 | Sale | Chief Financial Officer | 11,151 0.0099% | $32.66 | $364,192 | -2.62% | ||
| 2024-12-18 | Sale | Chief Human Resources Officer | 11,151 0.0099% | $32.66 | $364,192 | -2.62% | ||
| 2024-12-18 | Sale | CSTO | 12,742 0.0113% | $32.66 | $416,154 | -2.62% | ||
| 2024-12-16 | Sale | Chief Human Resources Officer | 25,000 0.0208% | $33.26 | $831,605 | -3.32% | ||
| 2024-12-11 | Sale | CSTO | 24,000 0.0201% | $35.77 | $858,401 | -7.98% | ||
| 2024-11-19 | Sale | director | 3,323 0.0027% | $42.12 | $139,973 | -11.91% | ||
| 2024-11-18 | Sale | Chief Human Resources Officer | 25,000 0.02% | $41.14 | $1.03M | -7.45% | ||
| 2024-11-06 | Sale | Chief Financial Officer | 41,137 0.0368% | $45.92 | $1.89M | -10.71% | ||
| 2024-10-21 | Sale | director | 5,000 0.0045% | $46.63 | $233,168 | -7.41% | ||
| 2024-10-16 | Sale | Chief Human Resources Officer | 25,000 0.0236% | $48.52 | $1.21M | -11.54% | ||
| 2024-10-07 | Sale | director | 30,000 0.0263% | $44.98 | $1.35M | +0.61% | ||
| 2024-10-01 | Sale | CSTO | 62,500 0.058% | $47.62 | $2.98M | -8.12% | ||
| 2024-09-23 | Sale | President and CEO | 32,880 0.0282% | $44.00 | $1.45M | +2.46% | ||
| 2024-09-23 | Sale | Chief Financial Officer | 11,510 0.0099% | $44.00 | $506,440 | +2.46% | ||
| 2024-09-23 | Sale | CSTO | 25,000 0.0214% | $43.95 | $1.1M | +2.46% | ||
| 2024-09-23 | Sale | Chief Human Resources Officer | 13,153 0.0113% | $44.00 | $578,737 | +2.46% | ||
| 2024-09-19 | Sale | director | 5,000 0.0045% | $45.73 | $228,658 | -2.56% | ||
| 2024-09-11 | Sale | CSTO | 111,394 0.0877% | $40.40 | $4.5M | +9.08% | ||
| 2024-09-11 | Sale | Chief Human Resources Officer | 25,000 0.0197% | $40.40 | $1.01M | +9.08% |
Insider Historical Profitability
| RTW INVESTMENTS, LP | 10 percent owner | 4795000 4.019% | $31.74 | 2 | 0 | <0.0001% |
| Cormorant Asset Management, LP | 2514545 2.1076% | $31.74 | 1 | 0 | <0.0001% |